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ABSTRACT 
Introduction 
Periodontitis may add to the systemic inflammatory burden in individuals with chronic 
kidney disease (CKD), thereby contributing to an increased morality rate. This study aimed to 
determine the association between periodontitis and mortality rate (all-cause and 
cardiovascular disease- related) in individuals with stage 3-5 CKD, hitherto referred to as 
“CKD”. 
 
Methods 
Survival analysis was carried out using the Third National Health and Nutrition Examination 
Survey (NHANES III) and linked mortality data.  Cox proportional hazards regression was 
employed to assess the association between periodontitis and mortality, in individuals with 
CKD. This association was compared with the association between mortality and traditional 
risk factors in CKD mortality (diabetes, hypertension and smoking).  
 
Results 
Of the 13,784 participants eligible for analysis in NHANES III, 861 (6%) had CKD. The 
median follow-up for this cohort was 14.3 years.  
Adjusting for confounders, the 10 year all-cause mortality rate for individuals with CKD 
increased from 32%(95%CI:29-35%) to 41%(36-47%) with the addition of periodontitis. For 
diabetes, the 10 year all-cause mortality rate increased to 43%(38-49%). 
Conclusion 
There is a strong, association between periodontitis and increased mortality in individuals 
with CKD. Sources of chronic systemic inflammation (including periodontitis) may be 
important contributors to mortality in patients with CKD. 
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Clinical Relevance: 
Scientific rationale for the study: CKD prevalence and complications cannot be entirely 
explained by traditional risk factors such as diabetes or cardiovascular disease (CVD). 
Periodontitis is independently associated with CKD and contributes to the systemic 
inflammatory burden, therefore this study aimed to establish the association between 
periodontitis and mortality in patients with chronic kidney disease (CKD). 
Principal Findings: Periodontitis was associated with a 9% (absolute) or 28% (relative) 
increase in all-cause mortality at 10 years for individuals with CKD, within the limitation of 
this analysis. This association is of a similar magnitude, but independent of, that seen 
between diabetes and mortality in individuals with CKD. 
Practical Implications: Periodontitis may be an important predictor of mortality in patients 
with CKD and sources of chronic inflammation (including periodontitis) may be important 
contributors beyond traditional risk factors in patients with CKD. 
 
 
Conflict of Interest: The authors declare that they have no competing interests. 
Sources of funding: Praveen Sharma is funded by a National Institute for Health Research 
(NIHR) Doctoral Research Fellowship and Charles J. Ferro is funded by an NIHR Post-
Doctoral Fellowship. The views expressed in this article are those of the authors and not 
necessarily those of the NHS, the NIHR or the Department of Health. 
 
INTRODUCTION 
Chronic kidney disease (CKD) affects between 8 and 13% of the global population (Jha et al., 
2013) and is associated with increased morbidity and mortality. Cardiovascular disease 
(CVD)-related events are the main cause of mortality in patients with CKD (Go et al., 2004) 
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and systemic inflammation is recognised as a non-traditional risk factor associated with 
increased risk of CVD events in such patients (Menon et al., 2005).  
Severe periodontitis is the sixth most common human disease (Kassebaum et al., 
2014) causing micro-ulceration of the investing sulcular and pocket lining epithelium of 
affected teeth. The estimated surface area of this ulcerated epithelium approximates 40cm2 in 
severe disease (Nesse et al., 2008). Consequently, individuals with periodontitis have 
elevated systemic markers of acute-phase (C-reactive protein/CRP, Interleukin-6/IL-6) and 
oxidative stress (peripheral neutrophil hyperactivity) responses. This has potential systemic 
consequences and co-morbid effects that have been implicated in other disease processes 
such as diabetes and CVD (Chapple et al., 2013, Tonetti et al., 2013).  
We have reported that patients with CKD have an increase in prevalence of 
periodontitis compared with community dwelling adults (Sharma et al., 2014). This finding is 
supported by a recent systematic review, reporting an association between periodontitis and 
CKD in several populations with a combined odds-ratio (OR) of 1.65 (95% confidence 
interval/CI: 1.53-2.01) (Chambrone et al., 2013).  
Successful periodontal treatment can reduce levels of systemic inflammation in 
patients with and without CKD (D'Aiuto et al., 2004, Fang et al., 2015, Siribamrungwong et 
al., 2014, Vilela et al., 2011). However, the only investigations into associations between 
periodontitis and mortality rates (all-cause and CVD) in patients with CKD have involved 
relatively small numbers of patients (ranging from 122-253 patients) on haemodialysis and 
with a short follow up period (ranging from 18 months to 6 years) (Chen et al., 2011, de 
Souza et al., 2014, Kshirsagar et al., 2009). In epidemiological studies reporting mortality 
outcomes from non-CKD populations some, (Garcia et al., 1998, Linden et al., 2012, Xu and 
Lu, 2011) but not all, (Avlund et al., 2009, Kim et al., 2013) report a significant positive 
association between periodontitis and an increased mortality rate.  
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The aim of this study was to evaluate the association between periodontitis and other 
traditional risk factors (diabetes, hypertension and smoking status) and mortality (all-cause 
and CVD) in individuals with stage 3-5 CKD, compared to those without using robust, large-
scale, population based data. 
 
MATERIALS AND METHODS 
Data Source 
Data were derived from the Third National Health and Nutrition Examination Survey 
(NHANES III, 1988-1994), a representative survey of the civilian, non-institutionalised US 
population conducted by the National Center for Health Statistics (NCHS) of the Center for 
Disease Control and Prevention. Details of the survey design and methodology are available 
elsewhere (NCHS, 2006a). Briefly, individuals were interviewed at home, then invited to a 
mobile examination centre (MEC) for further interviews, tests and examinations.  
 
Assessment of periodontal health 
Details of the oral health component of NHANES III are published elsewhere (Drury et al., 
1996). Briefly, detailed periodontal measurements were taken from volunteers aged 13 and 
over. The teeth were divided into two maxillary and two mandibular halves and 
measurements were taken from two sites per tooth (mid-buccal and mesio-buccal) for all 
teeth (excluding third molars) in one randomly chosen upper and lower quadrant. These 
measurements included periodontal probing depth (PPD), gingival recession and bleeding on 
probing (BOP). Clinical attachment loss (CAL) was calculated as the sum of the recession 
and PPD. Individuals receiving renal replacement therapy (through dialysis or kidney 
transplant) were excluded from periodontal examination. 
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Periodontitis was defined using the 2007 CDC/AAP (Centre for Disease Control and 
Prevention/American Academy of Periodontology) classification (Page and Eke, 2007). In 
addition, continuous periodontal parameters were also employed such as mean PPD, mean 
CAL, cumulative periodontal probing depth (C-PPD), number of teeth present and proportion 
of sites that bled upon probing. Cumulative PPD was calculated as the sum of the maximum 
probing pocket depths ≥4mm of each tooth and as such is a surrogate measure of the potential 
extent of biofilm exposed connective tissues (Dietrich et al., 2008). Edentulous individuals 
were included in the analyses but formed a group distinct from individuals with periodontitis. 
 
Assessment of CKD 
The serum creatinine levels recorded in the NHANES III survey were recalibrated to be 
traceable to an isotope-derived mass spectroscopy method using the equation below (NCHS, 
2006b): 
Standardised creatinine = (0.960 x serum creatinine) – 0.18 
Age, sex, ethnicity and standardised serum creatinine were incorporated in the CKD 
Epidemiology Collaboration (CKD-EPI) equation to calculate estimated glomerular filtration 
rate (eGFR) (Levey et al., 2009).  This equation improves mortality risk stratification in 
individuals with CKD compared with the Modification of Diet in renal Disease (MDRD) 
equation (Shafi et al., 2012). Based on an eGFR<60ml/min/1.73m2, individuals were 
classified as having stage 3-5 CKD, hitherto referred to as “CKD”. 
Urinary albumin and creatinine levels were employed to calculate the albumin-creatinine 
ratio (ACR). Details of the laboratory assays can be found elsewhere (NCHS, 2006b). 
Albuminuria was classified as ACR <30mg/g; ACR≥30 mg/g and <300mg/g; and 
ACR≥300mg/g. 
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Assessment of traditional risk factors 
Individuals were classed as hypertensive if their mean (of 3 consecutive measurements) 
systolic blood pressure (BP) was ≥140mmHg or mean diastolic BP was ≥90mmHg.  
Individuals were classed as diabetic by self-reporting (excluding gestational diabetes) or if 
their glycated haemoglobin (HbA1C) was ≥6.5%. 
Individuals’ smoking status was determined from self-reporting and classified into current, 
former or never smokers (cigarettes only). 
 
Covariate data 
Data on covariates employed in the statistical analyses included information on age, sex, 
ethnicity (Non-Hispanic White, Non-Hispanic Black, Mexican American or Other), alcohol 
consumption (never, not in last year, between 0-14 drinks/week, more than 14 drinks/week) 
and self-reported history of previous cardiovascular events (stroke, heart attack or heart 
failure). Pulse pressure was calculated as the difference between the mean systolic and 
diastolic BP. Self- reported measures of socio-economic status (household income, marital 
status and educational attainment) were coded as follows. Household income (less than 
$20,000 or $20,000 or more); marital status (married or living as married, never married, 
divorced or separated or widowed); educational attainment (less than high school, high 
school diploma or more than high school). Body mass index (BMI) was coded as a 
categorical variable with BMI <18.5kg/m2 as underweight; ≥ 18.5kg/m2 and <25kg/m2 as 
normal; ≥ 25kg/m2 and <30kg/m2 as overweight and ≥30kg/m2 as obese. Laboratory tests 
including serum cholesterol (total and high density lipoprotein/HDL) were performed. Serum 
cholesterol levels were classified into binary variables (total serum cholesterol ≥24mg/L or 
<24mg/L and serum HDL cholesterol ≤3.5mg/L or >3.5mg/L). Physical activity was self-
reported by individuals and reclassified as “recommended or more” if they reported moderate 
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activity five or more times a week or vigorous activity three or more times a week. Physical 
activity was also classified as “recommended or more” if individuals reported moderate 
physical activity four or more times a week and vigorous activity one or more times a week 
or reported moderate activity three or more times a week and vigorous activity two or more 
times a week. Individuals’ physical activity was classified as “none” if they reported no 
leisure time physical activities. Individuals who reported some level of physical activity but 
less than recommended were classed as “less than recommended” (Beddhu et al., 2009).  
 
Mortality data 
The NCHS provide mortality data for NHANES III participants up to 31st December 2006, 
linked by probabilistic record matching with the National Death Index (NDI). The publicly 
available dataset contains information on the mortality status of individuals aged 17 years or 
older. For individuals who are classified as “assumed deceased”, information is available on 
113 underlying cause of death categories, based on the ninth and tenth revisions of the 
International Classification of Diseases (ICD-9 and ICD-10).  CVD mortality was limited to 
cases where the underlying cause of death was coded between 53 and 75 (inclusive) 
(Anderson et al., 2001). Details of the linked mortality data have been published elsewhere 
(NCHS, 2010). 
 
Statistical analyses 
Analyses performed followed guidelines for NHANES III (NCHS, 1996), accounting for the 
complex survey design and sampling weights in order to yield estimates generalizable to the 
US population. Differences in categorical and continuous data were assessed for statistical 
significance using Pearson Chi-square, t-test, Fisher’s exact test and analysis of variance 
(ANOVA) as appropriate. Cox proportional hazards (PH) regression models were fitted to 
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evaluate the association between periodontal status, traditional risk factors (diabetes, 
hypertension and smoking status) and all-cause and CVD mortality, independent of potential 
confounders. The fully adjusted model adjusted for age, sex, ethnicity, CKD status, 
periodontal status, diabetic status, hypertensive status, smoking status, pulse pressure, history 
of CVD (heart attack or stroke or heart failure), alcohol consumption, ACR, 
hypercholesterolemia and low-HDL, BMI, physical activity and measures of socio-economic 
status (household income, marital status and educational attainment). The PH assumption was 
tested using Schoenfeld residuals, scaled Schoenfeld residuals and graphical methods. 
Variables were chosen to minimise missing data. Any individuals with missing covariate data 
were not included in the analyses (listwise deletion). Thus out of a possible 13,784 
individuals eligible for analyses, 1,379 (10%) individuals were excluded due to incomplete 
covariate data (Supplementary Table S1). 
We considered the effect measure modification of mortality (all-cause and 
cardiovascular) in individuals with CKD according to their periodontal health status.  We 
conducted formal tests of interaction between periodontal variables and CKD case definition 
by entering interaction terms in the model. Further formal tests of interactions between CKD, 
periodontitis or edentulism and age, gender and ethnicity were also carried out. 
Analyses were carried out using Stata/IC version 12.1 (StataCorp LP). 
 
RESULTS 
 
Description of whole population and subpopulations 
We analysed data from individuals in NHANES III aged 20 years and older with complete 
data on serum creatinine, periodontal status and mortality follow-up (n=13,784) and with a 
median follow-up time of 14.3 years (mean 13.5 years, range 1 month-18.2 years). Of the 
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13,794 individuals included in the analyses, 861 (6%) were classified as CKD and 12,923 as 
non-CKD. Individuals with CKD were more likely to be older, have different ethnic and 
socio-economic mix, non-smokers (never or ex- smokers), diabetic, hypertensive, with higher 
total serum cholesterol and lower levels of serum HDL, report lower levels of physical 
activity and consume less alcohol, and report a history of CVD (stroke, heart attack and 
congestive heart failure) compared to those without CKD. Individuals with CKD were more 
likely to suffer from periodontitis (or be edentulous) and have fewer teeth compared to 
individuals without CKD. When examining continuous variables of periodontal health, 
patients with CKD were more likely to have a greater mean CAL and greater BOP (Table 1). 
Among individuals with CKD, those with periodontitis were more likely to be older, 
of non-white ethnicity, current smokers, diabetic, and hypertensive and have a lower eGFR 
compared to periodontally healthy individuals. These individuals also had lower household 
incomes and educational attainments compared to periodontally healthy individuals. 
Periodontally healthy individuals were similar to those with periodontitis in terms of their 
sex, alcohol consumption, marital status, physical activity, history of CVD events and BMI 
(Table 1).  
 
All-cause mortality 
After adjusting for covariates, individuals with CKD had a 44% (95% CI: 28-63%) increased 
rate of all-cause mortality compared to those without CKD (Table 2). Individuals with 
periodontitis had a 36% (22-51%) increased rate of all-cause mortality compared to 
individuals who were periodontally healthy. 
The association between periodontitis and all-cause mortality was similar between 
individuals with or without CKD (p-value for interaction = 0.57). Similarly, the associations 
between CKD and all-cause mortality did not vary by age, sex or diabetes status (p-values for 
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interaction 0.14, 0.99 and 0.09 respectively). Furthermore, the association between 
periodontitis and all-cause mortality did not vary by age, gender or diabetes status (p-values 
for interaction 0.73, 0.51 and 0.51 respectively).  In edentulous individuals, there was a 
significant difference in all-cause mortality by age. Edentulous individuals under the age of 
65 had a significantly increased rate of all-cause mortality compared to edentulous 
individuals 65 years and older, hazard ratio (HR) 1.85 (1.41-2.44) and 1.18 (1.04-1.33) 
respectively (Supplementary Tables S2, S3 and Supplementary Figure S1).  
For continuous measures of periodontitis in fully adjusted models, an increased 
mortality rate was seen with worsening periodontal health in a dose-dependent manner. For 
example, a 1mm increase in mean PPD was associated with a 17% (6-28%) increase in 
incident rate of all-cause mortality (Table 2). Edentulousness was associated with a 32% (17-
50%) increased rate of all-cause mortality compared with periodontally healthy dentate 
individuals.  
Diabetes (HR 1.41; 1.27-1.57), hypertension (HR 1.06; 0.93-1.20), and current 
smoking (HR 2.12; 1.82-2.48) were associated with an increased rate of all-cause mortality 
although this increase was not significant for hypertension (Table 2). 
The 10 year all-cause mortality for individuals with CKD (but without periodontitis or 
other traditional risk factors) was 32% (29-35%). Addition of periodontitis to the risk profile 
increased 10 year mortality to 41% (36-47%). This increase in mortality was comparable with 
that seen in individuals with CKD who had diabetes instead of periodontitis (43%; 38-49%). 
A similar cumulative effect on mortality is seen with periodontitis and other traditional risk 
factors (Table 3). These estimates are based on the demographic features of individuals with 
CKD within NHANES III (for example, a mean age of 73 years). Estimated survival curves 
for individuals with CKD and different risk factor profiles is given in Figure 1. 
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Cardiovascular mortality 
After adjusting for covariates, individuals with CKD had a 60% (32-95%) increased 
rate of CVD mortality compared to those without CKD (Table 2), independent of 
confounders specified. Individuals with periodontitis had a 38% (16-65%) increased rate of 
CVD mortality compared to individuals who were periodontally healthy. The association 
between periodontitis and CVD mortality was similar between individuals with or without 
CKD (p-value for interaction = 0.27). The associations between CKD and CVD mortality did 
not vary by age, sex or diabetes status (p-values for interaction 0.39, 0.82 and 0.34 
respectively). The association between periodontitis CVD mortality did not vary by gender or 
diabetes status (p-values for interaction 0.77 and 0.17 respectively).  There was a trend in 
patients with CKD and periodontitis to have an increased HR of CVD mortality if they were 
under the age of 65 compared with 65 and over but this was not significant. In edentulous 
individuals, there was a significant difference in CVD mortality by age. Edentulous 
individuals under the age of 65 having a significantly increased rate of CVD mortality, HR 
2.03 (1.31-3.13), compared to edentulous individuals 65 years and older who had comparable 
rates of CVD mortality compared to periodontally healthy individuals, HR 0.89 (0.71-1.10) 
(Supplementary Tables S4, S5 and Supplementary Figures S2).  
For continuous measures of periodontal health, mean PPD and percentage of sites that 
bleed on probing were associated with a statistically significant increase in the rate of CVD 
mortality (Table 2).  Edentulous and periodontally healthy dentate individuals had 
comparable rates of CVD mortality (Table 2). 
 
Diabetes (HR 1.45; 1.24-1.70), hypertension (HR 1.32; 1.06-1.63) and current smoking (HR 
2.10; 1.69-2.62) were associated with an increased rate of CVD mortality (Table 2).  
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The 10 year CVD mortality for individuals with CKD (and combinations of risk 
factors) highlights the similarity in the magnitude of increase in CVD mortality associated 
with diabetes (24%; 19-30%) compared with periodontitis (22%; 19-27%) (Table 4). 
Estimated CVD survival for individuals with CKD and different risk factor profiles is given 
in Figure 2. 
 
DISCUSSION 
In this large cohort, representative of the US population from which it was derived, CKD was 
associated with increased rates of all-cause mortality and CVD mortality, independent of 
periodontitis, traditional risk factors and other confounders. Periodontitis was associated with 
increased rates of all-cause and CVD mortality comparable with, but independent of, that 
associated with diabetes (tables 2-4; figures 1-2). There was an increased rate of all-cause 
mortality but not CVD mortality in edentulous individuals with CKD compared with 
periodontally healthy dentate individuals. The association between edentulousness and CVD 
mortality was significant in a subgroup of edentulous individuals under the age of 65. Given 
the high prevalence of chronic periodontitis in patients with CKD (Chambrone et al., 2013), 
our results suggest that periodontitis may be an important non-traditional risk factor for CVD 
and all-cause mortality in these patients, and interestingly contributing to the increased risk to 
a similar extent as diabetes.  
The strengths of this study are its large population based sampling with robust 
sampling methodology which allow the results from this analysis to be generalised to the US 
population. The detailed clinical, demographic and anthropomorphic data collected allows for 
many of the known covariates to be accounted for in the Cox proportional hazards regression 
model, generating more accurate point estimates. The length of follow-up for this study is its 
final strength and allows for the pragmatic assessment of long term, hard outcomes (all-cause 
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and CVD mortality).  The limitations of this study include the lack of longitudinal 
examination of individuals.  Unfortunately, in NHANES, the longitudinal data is limited to 
the mortality status of patients derived from the National Death Index. Data on variables was 
only gathered at inception and therefore changes in variables (periodontal, diabetes, smoking 
status etc.), are not ascertainable. Analyses were carried out on the assumption that 
characteristics did not change between inception and time to death or censoring. Some 
individuals with periodontitis are likely to have received treatment and/or lost teeth during 
follow-up, resulting in disease misclassification over time. Furthermore, periodontal 
measurements from NHANES III are known to underestimate the prevalence of periodontitis 
by 13.4% (absolute) or 60% (relative) (Eke et al., 2010). The results of this study may 
therefore under-estimate the association between periodontitis and mortality in CKD. Also, as 
with any multi-variable regression analysis, the issue of residual confounding from inaccurate 
measurement or categorisation of variables or confounding from variables not included in the 
analysis cannot be ruled out.  
Previous studies investigating the link between mortality and periodontitis in patients 
with CKD have done so in patients on haemodialysis (Chen et al., 2011, de Souza et al., 
2014, Kshirsagar et al., 2009). Aside from the small sample sizes (122-253 patients) and 
shorter follow up period (18 months to 6 years), these studies differed significantly from the 
present analysis as individuals receiving RRT (through chronic dialysis or a functioning 
kidney transplant) were not included in the present analysis (RRT was an exclusion criteria 
for periodontal examination in NHANES III).  Hence, even though these studies demonstrate 
an association between periodontitis and mortality, thereby lending support to the current 
findings, the results cannot be directly compared. 
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A putative mechanism for a possible link between periodontitis and increased all-
cause and CVD mortality is via the increased systemic acute-phase and oxidative stress 
burden. This increased burden is seen in individuals with periodontitis and CKD (Ioannidou 
et al., 2011) and individuals with periodontitis who do not have CKD (Chapple et al., 2013, 
D'Aiuto et al., 2004).  Increased systemic inflammatory and oxidative stress burdens increase 
the incidence of CVD events in patients with CKD (Arici and Walls, 2001, Li et al., 2015, 
Mathew et al., 2008). This mechanism is supported by the association demonstrated here 
between increased risk of CVD mortality and measures of active periodontitis (periodontitis 
case definition, mean PPD and BOP), as opposed to measures of historical periodontitis 
(edentulousness and mean CAL), where there was a lack of association (Table 2). However, 
at least part of the association between periodontitis and CVD may also be due to common 
risk factors such as smoking and diabetes (Dietrich et al., 2008, Mucci et al., 2009). The 
increase in all-cause mortality in edentulous individuals compared to periodontally healthy 
dentate individuals, as reported here and also by other investigators in non-CKD cohorts 
(Brown, 2009), may be due to several factors. Patients are rendered edentulous for a variety 
of reasons including periodontitis, with approximately 50% of teeth being extracted due to 
periodontal disease (Phipps and Stevens, 1995). As approximately half of all tooth extractions 
are for reasons other than periodontal disease, edentulousness may act as a surrogate marker 
of general health attitudes and/or behaviours, limited healthcare access or other socio-
economic measures (Joshipura and Ritchie, 2005). This might also explain the association 
between edentulousness and CVD mortality in patients under the age of 65 who might have 
such characteristics and attitudes towards healthcare that render them edentulous before the 
age of 65.  
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The biological mechanisms underpinning the relationship between periodontitis and 
increased mortality in individuals with CKD form a promising area of research and may 
produce mechanistic targets leading to risk stratification and novel interventions. Ongoing 
longitudinal studies (Stringer et al., 2013) investigating large cohorts of patients with pre-
dialysis CKD may provide confirmation of this association and shed light upon explanatory 
mechanisms. Successful treatment of periodontitis has been shown to improve surrogate 
markers of CVD risk, including serum markers of systemic inflammation (CRP, IL-6) 
(D'Aiuto et al., 2004), endothelial function as measured by flow-mediated dilatation (FMD) 
and endothelial-activation markers such as soluble E-selectin and von Willebrand factor 
(Tonetti et al., 2007). Two randomised controlled trials of periodontal interventions in 
patients with CKD have been carried out but limited to cohorts of haemodialysis patients. 
These have produced conflicting results either not demonstrating changes in inflammatory 
markers following periodontal intervention (Wehmeyer et al., 2013) or demonstrating that 
significant reductions in inflammatory markers can be achieved following periodontal 
therapy (Fang et al., 2015). Currently, patients with CKD are managed to strict targets 
concerning glycaemic control (diabetes) and control of hypertension and smoking cessation 
in order to improve outcomes. If a causal link is established between periodontitis and 
increased rates of adverse outcomes in CKD patients, then establishing and maintaining 
periodontal health may become an important part of the care pathway of patients with CKD.  
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TABLES 
Table 1: Demographics of study population divided by CKD and periodontal status. Values 
are percentages (standard error) unless stated 
 
Characteristics 
No CKD  
(eGFR≥60ml/min/1.73m2) 
N=12,923 
CKD  
(eGFR<60ml/min/1.73m2) 
N=861 
p 
values
* 
p  
values 
**  
 Periodontal status Periodontal status   
 Healthy 
n=10,08
9 (78%) 
Periodontitis 
n=1,637 
(13%) 
Edentulous
n=1,197 
(9%) 
Healthy
n=357 
(41%) 
Periodontitis 
n=172 
(20%) 
Edentulous 
n=332 
(39%) 
<0.001 <0.001
Assumed         
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Deceased 
All-cause 
mortality 
11 35 56 70 88 87   
Cardiovascular 
mortality 
4 14 23 39 48 44   
Mean (SE) age 
(years) 
41 
(0.2) 
55 
(0.4) 
67 
(0.4) 
73 
(0.6) 
75 
(0.7) 
77 
(0.5) 
<0.001 0.03 
Female 55 
(0.4) 
37 
(1.2) 
54 
(1.4) 
54 
(2.6) 
45 
(3.8) 
55 
(2.7) 
0.95 0.07 
Ethnicity       <0.001 <0.001
Non-Hispanic 
White 
37 
(0.5) 
32 
(1.2) 
60 
(1.4) 
72 
(2.4) 
54 
(3.8) 
70 
(2.5) 
  
Non-Hispanic 
Black 
27 
(0.4) 
34 
(1.2) 
23 
(1.2) 
16 
(2.0) 
27 
(3.4) 
20 
(2.2) 
  
Mexican 
American 
31 
(0.4) 
30 
(1.1) 
13 
(1.0) 
8 
(1.4) 
17 
(2.9) 
6 
(1.3) 
  
Other 4 3 4 3 2 3   
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(0.2) (0.4) (0.5) (1.0) (1.0) (1.0) 
Current 
Smoker 
24 
(0.4) 
39 
(1.2) 
29 
(1.3) 
8 
(1.4) 
13 
(2.6) 
12 
(1.8) 
<0.001 0.03 
Diabetic 6.7 
(0.2) 
17.7 
(0.9) 
20.3 
(1.2) 
21.4 
(2.2) 
29.7 
(3.5) 
27.1 
(2.4) 
<0.001 0.04 
Hypertensive 16 
(0.3) 
33 
(1.2) 
44 
(1.4) 
54 
(2.6) 
65 
(3.6) 
59 
(2.7) 
<0.001 0.01 
Alcohol 
consumption 
      <0.001 0.07 
Never 17 (0.4) 16 (0.9) 25 (1.3) 22 (2.2) 27 (3.5) 35 (2.6)   
Not in last 
year 
33 (0.5) 40 (1.2) 49 (1.5) 47 (2.7) 51 (3.9) 53 (2.8)   
0-14 
drinks/week 
44 (0.5) 36 (1.2) 22 (1.2) 31 (2.5) 20 (3.1) 11 (1.8)   
>14 
drinks/week 
6 (0.2) 8 (0.7) 4 (0.5) 0.6 
(0.4) 
1 (0.8) 1 (0.5)   
History of 
stroke 
1.1 
(0.1) 
3.5 
(0.5) 
4.8 
(0.6) 
9 
(1.5) 
10 
(2.3) 
14 
(1.9) 
<0.001 0.75 
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History of 
heart attack 
1.9 
(0.1) 
5.1 
(0.5) 
7.8 
(0.8) 
12 
(1.7) 
15 
(2.8) 
17 
(2.0) 
<0.001 0.31 
History of 
congestive 
heart failure 
1.5 
(0.1) 
3.1 
(0.4) 
5.1 
(0.6) 
9 
(1.5) 
15 
(2.7) 
11 
(1.7) 
<0.001 0.07 
Mean (SE) 
eGFR 
(ml/min/1.73
m2) 
107 
(0.2) 
96 
(0.5) 
87 
(0.4) 
49 
(0.5) 
47 
(0.9) 
48 
(0.5) 
<0.001 0.005 
Mean (SE) 
ACR (mg/g) 
19.8 
(1.3) 
53.5 
(10.0) 
63.2 
(12.5) 
211 
(63.6) 
276 
(74.2) 
320 
(82.7) 
<0.001 0.54 
Mean (SE) 
BMI (kg/m2) 
27.1 
(0.06) 
27.6 
(0.15) 
27.0 
(0.16) 
27.5 
(0.27) 
26.8 
(0.40) 
26.5 
(0.27) 
0.27 0.16 
Total serum 
cholesterol 
(≥24mg/L) 
25 
(0.4) 
35 
(1.2) 
44 
(1.4) 
50 
(2.6) 
47 
(3.8) 
48 
(2.8) 
<0.001 0.512 
HDL 
cholesterol 
(≤3.5mg/L) 
11 
(0.3) 
17  
(0.9) 
13 
(1.0) 
18 
(2.0) 
16 
(2.9) 
20 
(2.2) 
<0.001 0.767 
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Pulse pressure 
(mm Hg) 
47 
(0.1) 
56 
(0.4) 
63 
(0.6) 
68 
(1.1) 
74 
(1.5) 
74 
(1.1) 
<0.001 0.002 
Marital status       <0.001 0.53 
Married (or 
living as 
married) 
63 
(0.5) 
65 
(1.2) 
57 
(1.4) 
56 
(2.6) 
51 
(3.8) 
45 
(2.7) 
  
Never married 21 
(0.4) 
9 
(0.7) 
5 
(0.6) 
5 
(1.2) 
5 
(1.6) 
2 
(0.8) 
  
Divorced or 
separated 
11 
(0.3) 
13 
(0.8) 
11 
(0.9) 
8 
(1.4) 
11 
(2.4) 
5 
(1.2) 
  
Widowed 5 
(0.2) 
12 
(0.8) 
26 
(1.3) 
31 
(2.5) 
33 
(3.6) 
48 
(2.7) 
  
Household 
income 
(<$20,000) 
43 
(0.5) 
57 
(1.2) 
66 
(1.4) 
55 
(2.7) 
68 
(3.6) 
72 
(2.5) 
<0.001 0.004 
Educational 
status 
      <0.001 <0.001
Less Than High 33 54 63 40 62 75   
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School (0.5) (1.2) (1.4) (2.6) (3.7) (2.4) 
High School 
Diploma 
(including 
GED) 
33 
(0.5) 
28 
(1.1) 
26 
(1.3) 
30 
(2.4) 
22 
(3.2) 
16 
(2.0) 
  
More Than 
High School 
34 
(0.5) 
18 
(1.0) 
11 
(0.9) 
30 
(2.5) 
16 
(2.8) 
9 
(1.6) 
  
Physical 
activity 
      <0.001 0.15 
None 18 
(0.4) 
25  
(1.1) 
30 
(1.3) 
25 
(2.3) 
33 
(3.6) 
39 
(2.7) 
  
Less than 
recommended 
44 
(0.5) 
43 
(1.2) 
36 
(1.4) 
36 
(2.5) 
34 
(3.6) 
29 
(2.5) 
  
Recommende
d or more 
38 
(0.5) 
32 
(1.2) 
34 
(1.4) 
39 
(2.6) 
33 
(3.6) 
32 
(2.7) 
  
Mean (SE) 
Teeth Present 
26 
(0.1) 
21 
(0.2) 
0 18 
(0.4) 
17 
(0.5) 
0 <0.001 0.10 
Mean (SE) CAL 0.9 3.1 N/A 1.6 3.6 N/A <0.001 <0.001
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(mm) (0.008) (0.04) (0.06) (0.11) 
Mean (SE) 
PPD (mm) 
1.5 
(0.004) 
2.2 
(0.02) 
N/A 1.4 
(0.2) 
1.9 
(0.6) 
N/A 0.77 <0.001
Mean (SE) C-
PPD (mm) 
1.8 
(0.04) 
11.4 
(0.3) 
N/A 1.0 
(0.2) 
7.1 
(0.8) 
N/A 0.53 <0.001
BOP  11 
(0.2) 
18 
(0.5) 
N/A 14 
(1.1) 
19 
(1.8) 
N/A <0.001 0.015 
ACR- albumin-creatinine ratio; BMI- body mass index; BOP- Percentage of sites that bleed 
on probing; CAL- clinical attachment loss; C-PPD- cumulative probing depth, eGFR- 
estimated glomerular filtration rate; HDL- high density lipoprotein; PPD- periodontal probing 
depth. 
*- comparing no CKD and CKD 
**- within individuals with CKD, comparing healthy and periodontitis 
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Table 2: Results from Cox proportional hazards regression analyses for all-cause and 
cardiovascular mortality using an age and sex adjusted and a fully adjusted model. 
 Hazard Ratio (95%CI) of All-cause 
mortality 
Hazard Ratio (95%CI) of 
Cardiovascular mortality 
 Age Adjusted Fully adjusted Age Adjusted Fully adjusted 
CKD 1.58 
(1.39 to 1.80) 
1.44 
(1.28 to 1.63) 
1.81 
(1.55 to 2.14) 
1.60 
(1.32 to 1.95) 
Periodontal 
status 
    
Healthy 1.0 
(Ref) 
1.0 
(Ref) 
1.0 
(Ref) 
1.0 
(Ref) 
Periodontitis 1.78 
(1.59 to 2.00) 
1.36 
(1.22 to 1.51) 
1.79 
(1.52 to 2.11) 
1.38 
(1.16 to 1.65) 
Edentulous 1.83 
(1.64 to 2.05) 
1.32 
(1.17 to 1.50) 
1.47 
(1.24 to 1.73) 
1.05 
(0.85 to 1.29) 
Continuous 
periodontal 
variables 
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Mean PPD 
(per mm) 
1.48 
(1.35 to 1.62) 
1.17 
(1.06 to  1.28) 
1.51 
(1.34 to 1.72) 
1.21 
(1.05 to 1.40) 
Mean CAL 
(per mm) 
1.20 
(1.16 to 1.25) 
1.09 
(1.05 to 1.14) 
1.16 
(1.11 to 1.22) 
1.05 
(0.99 to 1.12) 
C-PPD (per 10 
mm) 
1.29 
(1.20 to 1.38) 
1.08 
(1.01 to 1.17) 
1.35 
(1.19 to 1.54) 
1.16 
(0.99 to 1.35) 
BOP (per 
10%) 
1.10 
(1.07 to 1.13) 
1.05 
(1.02 to 1.08) 
1.10 
(1.06 to 1.13) 
1.05 
(1.01 to 1.09) 
Diabetes 1.85 
(1.63 to 2.10) 
1.41 
(1.27 to 1.57) 
2.00 
(1.71 to 2.35) 
1.45 
(1.24 to 1.70) 
Hypertension 1.28 
(1.15 to 1.43) 
1.06 
(0.93 to 1.20) 
1.52 
(1.31 to 1.77) 
1.32 
(1.06 to 1.63) 
Smoking 
status 
    
Never 1.0 
(Ref) 
1.0 
(Ref) 
1.0 
(Ref) 
1.0 
(Ref) 
Former 1.41 1.25 1.32 1.18 
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BOP- Proportion of sites that bleed on probing; CAL- clinical attachment loss; CKD- chronic 
kidney disease; C-PPD- cumulative periodontal probing depth; PPD- periodontal probing 
depth 
Fully adjusted model adjusted for age, sex, ethnicity, CKD status, periodontal status, diabetic 
status, hypertensive status, smoking status, pulse pressure, history of CVD (heart attack or 
stroke or heart failure), alcohol consumption, ACR, hypercholesterolemia and low-HDL, BMI, 
physical activity and measures of socio-economic status (household income, marital status 
and educational attainment). 
 
 
 
 
 
 
 
(1.23 to 1.60) (1.09 to 1.43) (1.11 to 1.56) (0.98 to 1.42) 
Current 2.70 
(2.35 to 3.09) 
2.12 
(1.82 to 2.48) 
2.44 
(2.05 to 2.91) 
2.10 
(1.69 to 2.62) 
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Table 3: 10 year all-cause mortality (percentages) of individuals with CKD by risk factors 
(along with the addition of periodontitis to the risk factor) 
Risk Factor 10 year all-cause mortality (95%CI) 
without periodontitis 
10 year all-cause mortality (95%CI)  
with periodontitis 
CKD 32% (29 to 35%) 41% (36 to 47%) 
CKD + Diabetes 43% (38 to 49%) 55% (47 to 63%) 
CKD + 
Hypertension 
34% (29 to 39%) 44% (37 to 52%) 
CKD + Smoking 58% (51 to 65%) 71% (62 to 79%) 
Fully adjusted model adjusted for age, sex, ethnicity, CKD status, periodontal status, diabetic 
status, hypertensive status, smoking status, pulse pressure, history of CVD (heart attack or 
stroke or heart failure), alcohol consumption, ACR, hypercholesterolemia and low-HDL, BMI, 
physical activity and measures of socio-economic status (household income, marital status 
and educational attainment). 
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Table 4: 10 year CVD mortality (percentages) of individuals with CKD by risk factors (along 
with the addition of periodontitis to the risk factor) 
Fully adjusted model adjusted for age, sex, ethnicity, CKD status, periodontal status, diabetic 
status, hypertensive status, smoking status, pulse pressure, history of CVD (heart attack or 
stroke or heart failure), alcohol consumption, ACR, hypercholesterolemia and low-HDL, BMI, 
physical activity and measures of socio-economic status (household income, marital status 
and educational attainment). 
 
Figure Legends 
Figure 1: For all-cause mortality. Cox proportional hazard regression graphs (adjusting for 
age, sex, ethnicity, pulse pressure, history of CVD, alcohol consumption, ACR, 
hypercholesterolemia and low-HDL, BMI, physical activity, household income, marital status 
 
Risk Factor 
10 year CVD mortality (95%CI)  
without periodontitis 
10 year CVD mortality (95%CI)  
with periodontitis 
CKD 16% (14 to 19%) 22% (19 to 27%) 
CKD + Diabetes 24% (19 to 30%) 32% (27 to 39%) 
CKD + 
Hypertension 
21% (16 to 28%) 29% (22 to 37%) 
CKD + Smoking 33% (24 to 44%) 43% (32 to 56%) 
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and educational attainment) of survival in patients with CKD stratified using periodontitis 
and other traditional risk factors (diabetes, hypertension and smoking). The reference lines 
indicate 10 year survival. 
Figure 2: For cardiovascular mortality. Cox proportional hazard regression graphs (adjusting 
for age, sex, ethnicity, pulse pressure, history of CVD, alcohol consumption, ACR, 
hypercholesterolemia and low-HDL, BMI, physical activity, household income, marital status 
and educational attainment) of survival in patients with CKD stratified using periodontitis 
and other traditional risk factors (diabetes, hypertension and smoking). The reference lines 
indicate 10 year survival. 
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